Shingles pain breakthrough? injections may beat standard drugs
NCT ID NCT06344403
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether injecting a mix of lidocaine and steroids into tender points can better relieve shingles pain compared to standard painkillers alone. The trial involves 136 adults with severe shingles pain for less than 90 days. Researchers will track pain levels for up to 12 months to see if the injections reduce the chance of long-term nerve pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lidocaine and diprospan (steroid) injected into tender points
- What this could lead to
- If it works, this could offer a more effective way to manage shingles pain and reduce the risk of long-term nerve pain.
- What could go wrong
- This is a small, early-stage trial with no phase designation, so results may not be conclusive. The injections carry risks like infection or allergic reaction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100070, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Your genes may hold the key to predicting Post-Surgical pain
- Unlocking the mystery of persistent pain after breast surgery
- Could a pill replace a needle for emergency pain relief?
- Can mRNA technology outsmart shingles? a new vaccine trial aims to find out
- A simple fan could cool away IV needle pain